BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20084279)

  • 1. Common genetic variants and risk for HPV persistence and progression to cervical cancer.
    Wang SS; Gonzalez P; Yu K; Porras C; Li Q; Safaeian M; Rodriguez AC; Sherman ME; Bratti C; Schiffman M; Wacholder S; Burk RD; Herrero R; Chanock SJ; Hildesheim A
    PLoS One; 2010 Jan; 5(1):e8667. PubMed ID: 20084279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.
    Wang SS; Bratti MC; Rodríguez AC; Herrero R; Burk RD; Porras C; González P; Sherman ME; Wacholder S; Lan ZE; Schiffman M; Chanock SJ; Hildesheim A
    J Infect Dis; 2009 Jan; 199(1):20-30. PubMed ID: 19012493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
    Safaeian M; Hildesheim A; Gonzalez P; Yu K; Porras C; Li Q; Rodriguez AC; Sherman ME; Schiffman M; Wacholder S; Burk R; Herrero R; Burdette L; Chanock SJ; Wang SS
    PLoS One; 2012; 7(4):e33619. PubMed ID: 22496757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in the
    Dardiotis E; Siokas V; Garas A; Paraskevaidis E; Kyrgiou M; Xiromerisiou G; Deligeoroglou E; Galazios G; Kontomanolis EN; Spandidos DA; Tsatsakis A; Daponte A
    Oncol Lett; 2018 Sep; 16(3):3833-3841. PubMed ID: 30127996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.
    Koshiol J; Hildesheim A; Gonzalez P; Bratti MC; Porras C; Schiffman M; Herrero R; Rodriguez AC; Wacholder S; Yeager M; Chanock SJ; Burk RD; Wang SS
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1631-7. PubMed ID: 19423538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of the dUTPase-encoding gene DUT increase HR-HPV infection rate and cervical squamous cell carcinoma risk.
    Ye F; Wang H; Liu J; Cheng Q; Chen X; Chen H
    Sci Rep; 2019 Jan; 9(1):513. PubMed ID: 30679536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
    Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
    Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
    Castro FA; Ivansson EL; Schmitt M; Juko-Pecirep I; Kjellberg L; Hildesheim A; Gyllensten UB; Pawlita M
    Int J Cancer; 2012 Jan; 130(2):349-55. PubMed ID: 21387292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
    Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
    Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis and oncogenic HPV: potential co-infections in women at high-risk of cervical cancer in rural China.
    Zhao FH; Varanasi AP; Cunningham CA; Graubard BI; Hu SY; Chen F; Barrett CJ; Qiao YL; Forman MR
    Asian Pac J Cancer Prev; 2011; 12(6):1409-15. PubMed ID: 22126473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
    Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
    Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
    Mukherjee A; Ye Y; Wiener HW; Kuniholm MH; Minkoff H; Michel K; Palefsky J; D'Souza G; Rahangdale L; Butler KR; Kempf MC; Sudenga SL; Aouizerat BE; Ojesina AI; Shrestha S
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1190-1197. PubMed ID: 37410084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carcinogenicity of human papillomavirus types reflects viral evolution.
    Schiffman M; Herrero R; Desalle R; Hildesheim A; Wacholder S; Rodriguez AC; Bratti MC; Sherman ME; Morales J; Guillen D; Alfaro M; Hutchinson M; Wright TC; Solomon D; Chen Z; Schussler J; Castle PE; Burk RD
    Virology; 2005 Jun; 337(1):76-84. PubMed ID: 15914222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
    Zelmanowicz Ade M; Schiffman M; Herrero R; Goldstein AM; Sherman ME; Burk RD; Gravitt P; Viscidi R; Schwartz P; Barnes W; Mortel R; Silverberg SG; Buckland J; Hildesheim A
    Int J Cancer; 2005 Sep; 116(4):599-605. PubMed ID: 15818615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
    BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
    Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
    Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
    Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
    J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women.
    Bae JH; Cheung JL; Lee SJ; Luk AC; Tong SY; Chan PK; Park JS
    J Microbiol Biotechnol; 2009 Sep; 19(9):1051-4. PubMed ID: 19809265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
    Madsen BE; Ramos EM; Boulard M; Duda K; Overgaard J; Nordsmark M; Wiuf C; Hansen LL
    PLoS One; 2008 Jun; 3(6):e2492. PubMed ID: 18575592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional variant of the P2X7 receptor gene is associated with human papillomavirus-16 positive cervical squamous cell carcinoma.
    Yang YC; Chang TY; Chen TC; Lin WS; Chang SC; Lee YJ
    Oncotarget; 2016 Dec; 7(50):82798-82803. PubMed ID: 27779103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.